AKTX
Akari Therapeutics Plc ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.23
-0.03 ▼ -10.71%
🌙 3월 13일 7:04 PM ET (한국 3/14 08:04)
$0.23
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -0.48 | Insider Own | 0.4% | Shs Outstand | 0.03B | Perf Week | -8.76% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 20% | Insider Trans | - | Shs Float | 0.03B | Perf Month | -6.68% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.04 | Inst Own | 13.68% | Short Float | 0.64% | Perf Quarter | -39.7% |
| Income | -0.02B | P/S | - | EPS this Y | 87.59% | Inst Trans | 13.16% | Short Ratio | 0.29 | Perf Half Y | -70.23% |
| Sales | 0.00B | P/B | 0.33 | EPS next 5Y | 52.62% | ROA | -65.41% | Short Interest | 0.21M | Perf YTD | -20.69% |
| Book/sh | 0.7 | P/C | 2.94 | EPS past 3/5Y | - | ROE | -196.77% | 52W High | -86.75% ($1.73) | Perf Year | -74.75% |
| Cash/sh | 0.08 | P/FCF | - | Sales past 3/5Y | - | ROIC | -69.36% | 52W Low | 5.23% ($0.22) | Perf 3Y | -96.05% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 13.57% | Gross Margin | - | Volatility(W/M) | 11.74% 10.64% | Perf 5Y | -99.63% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.03 | Perf 10Y | -99.89% |
| Dividend Ex-Date | - | Quick Ratio | 0.19 | EPS Q/Q | 17.99% | Profit Margin | - | RSI (14) | 40.16 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.19 | Sales Q/Q | - | SMA20 | -6.69% ($0.25) | Beta | 0.28 | Target Price | $1 |
| Payout | - | Debt/Eq | 0.09 | Earnings | 2025/12/05 | SMA50 | -10.22% ($0.26) | Rel Volume | 1.29 | Prev Close | $0.26 |
| Employees | 9 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -150% - | SMA200 | -67.28% ($0.7) | Avg Volume(3M) | 0.72M | Price | $0.23 |
| IPO | 2013/5/7 | Option/Short | No/Yes | Trades | 1135 | Volume | 929,871 | Change | -10.71% |
뉴스 로딩 중...